½ÃÀ庸°í¼­
»óǰÄÚµå
1591861

°¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå : °Ë»ç À¯Çü, ÇüÅÂ, »ùÇà À¯Çüº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Home Testing Kits Market by Test Type (Drug Abuse Test Kit, HIV Test Kit, Ovulation Predictor Test Kit), Form (Cassette, Midstream, Strip), Sample Type - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 38¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 40¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.78%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 60¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°¡Á¤¿ë °Ë»ç ŰƮÀÇ Àû¿ë ¹üÀ§´Â ÀÇ·á Áø´Ü¿¡¼­ »ýȰ½À°ü ¹× ¿µ¾ç °Ë»ç¿¡ À̸£±â±îÁö ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ¾î ±âÁ¸ÀÇ ½ÇÇè½Ç °Ë»ç¿¡ ´ëÇÑ Æí¸®ÇÏ°í ºñ°ø°³ÀûÀÌ¸ç ½Å¼ÓÇÑ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Å°Æ®´Â ƯÈ÷ Äڷγª19¿Í °°Àº ÆÒµ¥¹Í »óȲ¿¡¼­ Àû½Ã °Ë»ç°¡ ¸Å¿ì Áß¿äÇÑ ¿À´Ã³¯°ú °°ÀÌ ºü¸£°Ô º¯È­ÇÏ´Â ¼¼»ó¿¡¼­ ½Å¼ÓÇÑ °Ç°­ ÅëÂû·ÂÀ» Á¦°øÇϰí Àû±ØÀûÀÎ °Ç°­ °ü¸®¸¦ ÃËÁøÇϱâ À§ÇØ Á¡Á¡ ´õ ¸¹ÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀڷδ °³ÀÎ ¼ÒºñÀÚ, ¿ø°Ý ÀÇ·á ½Ã¼³, ±×¸®°í ÀæÀº º´¿ø ¹æ¹® ¾øÀ̵µ Á¤±âÀûÀÎ ¸ð´ÏÅ͸µÀ» ¿øÇÏ´Â °í·ÉÈ­ Àα¸°¡ ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â AI¿Í °°Àº Áø´Ü ±â¼ú ¹ßÀü, °Ç°­¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀÎ½Ä Áõ°¡, ºÐ»êÇü ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä´Â ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ ºñÁî´Ï½º ±âȸ´Â »õ·Î¿î °Ç°­ ÁöÇ¥¸¦ À§ÇÑ Ã·´Ü °Ë»ç ŰƮÀÇ °³¹ß, ¿ø°Ý °Ç°­ ¸ð´ÏÅ͸µ ¿¬°á °­È­, ±×¸®°í ±ÔÁ¦ º¯È­¿¡ µû¸¥ ½ÅÈï ½ÃÀå ÁøÃâ¿¡ ÀÖ½À´Ï´Ù. ±×·¯³ª ±ÔÁ¦ À庮, ÀÓ»ó ±âÁØ¿¡ ºÎÇÕÇÏ´Â Á¤È®¼º°ú ½Å·Ú¼º È®º¸, ¼ÒºñÀÚ µ¥ÀÌÅÍ¿¡ ´ëÇÑ ÇÁ¶óÀ̹ö½Ã ¹®Á¦ µîÀÌ ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼ÒÇüÈ­ ¹ÙÀÌ¿À¼¾¼­ ¿¬±¸¸¦ ÅëÇÑ Çõ½Å ÃËÁø, µ¥ÀÌÅÍ º¸¾ÈÀ» À§ÇÑ ºí·ÏüÀÎ ÅëÇÕ, »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º °³¼± µîÀº ÇâÈÄ ¼ºÀåÀÇ Å« ÀáÀç·ÂÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀåÀº º»ÁúÀûÀ¸·Î ¿ªµ¿ÀûÀ̸ç, Çõ½Å°ú ¼ÒºñÀÚ Çൿ¿¡ ÀÇÇØ ¿òÁ÷À̸ç, ƯÈ÷ ¿ø°Ý ÀÇ·á ¿¬°è ¹× ¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å Ç÷§Æû¿¡¼­ À¯¸®ÇÑ ±æÀ» Á¦½ÃÇÕ´Ï´Ù. ±â¼ú Çõ½Å°ú ±ÔÁ¦ ¾÷µ¥ÀÌÆ®¿¡ ´ëÀÀÇÏ´Â °ÍÀº À§ÇèÀ» ÁÙÀ̸鼭 °ü·Ã ÀÌÀÍÀ» ÃÖÀûÈ­ÇϰíÀÚ ÇÏ´Â ÀÌÇØ°ü°èÀڵ鿡°Ô ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¾ß¿¡ ÁýÁßÇÔÀ¸·Î½á ±â¾÷Àº ÇコÄÉ¾î »ê¾÷À» º¸´Ù °³ÀÎÈ­µÇ°í ¼ÒºñÀÚ Áß½ÉÀÇ ¹Ì·¡·Î À̲ô´Â ¼¿ÇÁÄÉ¾î ¹× ¿¹¹æÀû °Ç°­°ü¸® Æ®·»µå¿¡ Å« ±â¿©¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 38¾ï ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 40¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 60¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 6.78%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

°¡Á¤¿ë Áø´ÜŰƮ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÀÇ·áºñ Àý°¨À» À§ÇÑ µµÀÔ È®´ë
    • ½´ÆÛ¸¶ÄÏ ¹× ¾à±¹¿¡¼­ °¡Á¤¿ë °Ë»ç ŰƮÀÇ °¡¿ë¼º ¹× Á¢±Ù¼º Çâ»ó
    • °¡Ã³ºÐ¼Òµæ Áõ°¡¿Í ÇÔ²² ´ç´¢º´, ½ÉÇ÷°ü Áúȯ µîÀÇ Áúº´ À¯º´·ü Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇÑ ³·Àº Á¤È®µµ¿Í Àú·ÅÇÑ °¡°Ý´ë
    • Á¦Ç° ȸ¼ö À§Çè
  • ½ÃÀå ±âȸ
    • Á¤È®µµ¸¦ Çâ»ó½ÃŰ´Â ±â¼ú ¹ßÀü°ú °¡Á¤¿ë °Ë»ç ŰƮÀÇ µîÀå
    • ´Ù¾çÇÑ ¹Î°£-°ø°ø±â°üÀÇ ¿¬±¸°³¹ß Áõ°¡
  • ½ÃÀå °úÁ¦
    • Áö¹æÀÇ °Ë»ç¿¡ ´ëÇÑ ¼Ò±ØÀû ŵµ¿Í ÀÎ½Ä ÀúÇÏ

Portre's Five Forces: °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

"Portre's Five Forces" ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº °¡Á¤¿ë Å×½ºÆ® ŰƮ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

°¡Á¤¿ë Å×½ºÆ® ŰƮ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â °¡Á¤¿ë Áø´ÜŰƮ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

°¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

°¡Á¤¿ë Áø´ÜŰƮ ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå : Å×½ºÆ® À¯Çüº°

  • ¾à¹° ³²¿ë °Ë»ç ŰƮ
  • HIV °Ë»ç ŰƮ
  • ¹è¶õ ¿¹Ãø °Ë»ç ŰƮ
  • ÀӽŠ°Ë»ç

Á¦7Àå °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå : Çüź°

  • Ä«¼¼Æ®
  • ¹Ìµå½ºÆ®¸²
  • ½ºÆ®¸³

Á¦8Àå °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå : »ùÇà À¯Çüº°

  • Ç÷¾×
  • Ÿ¾×
  • ¼Òº¯

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦112Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °¡Á¤¿ë °Ë»ç ŰƮ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • BAYADA Home Health Care
  • Care UK Group
  • ConvaTec Group PLC
  • Drive DeVilbiss International
  • F. Hoffmann-La Roche Ltd.
  • Hamilton Health Care System
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • LHC Group, Inc.
  • Linde PLC
  • Lowenstein Medical SE & Co. KG
  • McKesson Corporation
  • Medline Industries, LP
  • OMRON Healthcare, Inc.
  • Vitalograph Ltd.
LSH

The Home Testing Kits Market was valued at USD 3.80 billion in 2023, expected to reach USD 4.04 billion in 2024, and is projected to grow at a CAGR of 6.78%, to USD 6.02 billion by 2030.

The scope of home testing kits encompasses a broad range of applications from medical diagnostics to lifestyle and nutritional testing, offering a convenient, private, and swift alternative to traditional laboratory tests. These kits are increasingly necessary in today's fast-paced world for providing rapid health insights and facilitating proactive health management, especially in pandemic scenarios like COVID-19 where timely testing is crucial. The primary end-users include individual consumers, remote healthcare facilities, and aging populations looking for regular monitoring without frequent clinical visits. Key growth factors influencing this market include technological advancements like AI in diagnostics, increasing consumer awareness about health, and the demand for decentralized healthcare solutions. Additionally, the rising prevalence of chronic diseases and the demand for personalized medicine fuel this market's expansion. Noteworthy opportunities lie in developing advanced testing kits for new health metrics, enhancing remote health monitoring connectivity, and expanding into emerging markets with supportive regulatory changes. However, challenges such as regulatory hurdles, ensuring accuracy and reliability that matches clinical standards, and privacy concerns regarding consumer data could limit market growth. Empowering innovation through research in miniaturized biosensors, integrating blockchain for data security, and improving user-friendly interfaces represent substantial potential for future growth. The home testing kits market is inherently dynamic, driven by innovation and consumer behavior, and presents lucrative avenues particularly in telehealth collaborations and direct-to-consumer platforms. Keeping pace with technological innovations and regulatory updates is crucial for stakeholders aiming to optimize the associated benefits while mitigating risks. By focusing on these areas, businesses can significantly contribute to self-care and preventative health management trends that are increasingly propelling the healthcare industry into a more personalized and consumer-centric future.

KEY MARKET STATISTICS
Base Year [2023] USD 3.80 billion
Estimated Year [2024] USD 4.04 billion
Forecast Year [2030] USD 6.02 billion
CAGR (%) 6.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Home Testing Kits Market

The Home Testing Kits Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Augment in adoption to reduce healthcare expenses
    • Rising availability and accessibility of home testing kits at supermarkets and pharmacies
    • Growing prevalence of diseases such as diabetes and cardiovascular diseases coupled with rising disposable income
  • Market Restraints
    • Dearth of precision and affordability due to high cost
    • Probable risks of product recalls
  • Market Opportunities
    • Advancement in technologies with increased accuracy and new testing kits at home
    • Increasing research and development from various private and public organizations
  • Market Challenges
    • Reduced reluctance and awareness of testing in rural areas

Porter's Five Forces: A Strategic Tool for Navigating the Home Testing Kits Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Home Testing Kits Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Home Testing Kits Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Home Testing Kits Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Home Testing Kits Market

A detailed market share analysis in the Home Testing Kits Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Home Testing Kits Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Home Testing Kits Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Home Testing Kits Market

A strategic analysis of the Home Testing Kits Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Home Testing Kits Market, highlighting leading vendors and their innovative profiles. These include BAYADA Home Health Care, Care UK Group, ConvaTec Group PLC, Drive DeVilbiss International, F. Hoffmann-La Roche Ltd., Hamilton Health Care System, Invacare Corporation, Koninklijke Philips N.V., LHC Group, Inc., Linde PLC, Lowenstein Medical SE & Co. KG, McKesson Corporation, Medline Industries, LP, OMRON Healthcare, Inc., and Vitalograph Ltd..

Market Segmentation & Coverage

This research report categorizes the Home Testing Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Drug Abuse Test Kit, HIV Test Kit, Ovulation Predictor Test Kit, and Pregnancy Test.
  • Based on Form, market is studied across Cassette, Midstream, and Strip.
  • Based on Sample Type, market is studied across Blood, Saliva, and Urine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Augment in adoption to reduce healthcare expenses
      • 5.1.1.2. Rising availability and accessibility of home testing kits at supermarkets and pharmacies
      • 5.1.1.3. Growing prevalence of diseases such as diabetes and cardiovascular diseases coupled with rising disposable income
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of precision and affordability due to high cost
      • 5.1.2.2. Probable risks of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in technologies with increased accuracy and new testing kits at home
      • 5.1.3.2. Increasing research and development from various private and public organizations
    • 5.1.4. Challenges
      • 5.1.4.1. Reduced reluctance and awareness of testing in rural areas
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Home Testing Kits Market, by Test Type

  • 6.1. Introduction
  • 6.2. Drug Abuse Test Kit
  • 6.3. HIV Test Kit
  • 6.4. Ovulation Predictor Test Kit
  • 6.5. Pregnancy Test

7. Home Testing Kits Market, by Form

  • 7.1. Introduction
  • 7.2. Cassette
  • 7.3. Midstream
  • 7.4. Strip

8. Home Testing Kits Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Saliva
  • 8.4. Urine

9. Americas Home Testing Kits Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Home Testing Kits Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Home Testing Kits Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BAYADA Home Health Care
  • 2. Care UK Group
  • 3. ConvaTec Group PLC
  • 4. Drive DeVilbiss International
  • 5. F. Hoffmann-La Roche Ltd.
  • 6. Hamilton Health Care System
  • 7. Invacare Corporation
  • 8. Koninklijke Philips N.V.
  • 9. LHC Group, Inc.
  • 10. Linde PLC
  • 11. Lowenstein Medical SE & Co. KG
  • 12. McKesson Corporation
  • 13. Medline Industries, LP
  • 14. OMRON Healthcare, Inc.
  • 15. Vitalograph Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦